The Health Attribution Library is a curated “living” database compiling peer-reviewed studies that quantify human-health impacts of anthropogenic climate change through end-to-end detection and attribution analysis.

This month’s sustainable-finance roundup highlights faster transition momentum, rising physical risks and a tightening focus on accountability. COP30 reinforced expectations for stronger 2035 targets, while national actions underscored diverging paths toward decarbonisation. Markets continued shifting toward clean energy and resilience, and new science made climate harms more visible. With regulatory scrutiny and litigation increasing, transition credibility and real-economy resilience are becoming core drivers of financial risk and investment decisions.

This report examines how ChatGPT can expose teenagers to harmful content, including self-harm, disordered eating and substance abuse guidance. Researchers posing as 13-year-olds found safeguards were easily bypassed, with over half of tested prompts generating unsafe outputs. The report calls for stronger age controls, transparency, and safety enforcement.

This case study explores how Access Bank integrates the UN Principles for Responsible Banking into its operations, advancing green finance, financial inclusion, and gender equality. It highlights the bank’s green bond issuances, ESG frameworks, and stakeholder engagement, offering investors insight into sustainable finance practices within emerging markets.

This report by Roots of Impact (2024) reviews eight years of experience implementing Impact-Linked Finance (ILF), a structuring approach that rewards measurable social or environmental outcomes by linking financial terms to impact performance. It outlines ILF’s evolution, design principles, effectiveness benchmarks, and opportunities to scale through collaboration and new impact-linked instruments.

MDPI (Multidisciplinary Digital Publishing Institute) is a Swiss-based publisher of open access, peer-reviewed journals, established in 1996. MDPI publishes over 470 academic journals across science, technology and medicine, with authors covering article processing charges to enable unrestricted global access.

The Tobacco Supply Chain tool is a publicly accessible database mapping the global tobacco supply chain from agriculture to retail by identifying companies, processes and countries involved.

This report presents an updated “Doughnut” framework, tracking 35 social and ecological indicators from 2000–2022. Findings show only modest progress on reducing deprivation, while ecological overshoot has worsened, with wealthier nations driving most impacts. The study highlights stark inequalities and calls for regenerative, distributive economic approaches.

SCP-HAT (Sustainable Consumption and Production Hotspots Analysis Tool) is an online tool that maps national and sector-level “hotspots” of unsustainable production and consumption using input-output and lifecycle methodologies.

Tobacco Tactics is a knowledge-exchange platform from the University of Bath’s Tobacco Control Research Group. It compiles rigorous academic research and monitoring on the global tobacco industry—its products, influences, themes and companies—in an accessible format.

Tobacco Control Research Group (TCRG) at the University of Bath conducts international, multidisciplinary research into the tobacco industry’s influence on health and policy. TCRG generates evidence to support effective tobacco control, informs public health policy, and provides training on industry monitoring and accountability to advance global health outcomes.

The Point of No Returns benchmark series assesses the world’s largest asset managers on responsible investment across climate, biodiversity, social issues, governance, and stewardship. Published by ShareAction, the series provides rankings, sector-wide analysis, and examples of practice to guide improvement and accountability.

This report analyses the relationship between sovereign ESG risks and credit risk across 70 countries. Using FTSE Russell/Beyond Ratings data and five-year CDS spreads, it finds stronger financial materiality of ESG risks in emerging and high-yield markets, particularly for social and governance factors, with weaker results for environmental risks.

This report examines the barriers to bringing new antibiotics to market, highlighting funding gaps, regulatory uncertainty, and weak commercial incentives. It outlines policy solutions to improve access and development, aiming to address the growing threat of antimicrobial resistance (AMR) by supporting viable pathways for pharmaceutical innovation.

The report outlines how strategic investment can reduce animal testing in the health sector. It provides investors with guidance on promoting transparency, encouraging non-animal methods, and influencing regulation, while highlighting the risks of limited disclosure and misalignment with consumer concerns.

Companies excelling in disability inclusion earn higher revenue, profit, and productivity. Despite rising interest, action lags. Barriers include disclosure fears and cost assumptions. The report introduces a five-part “A List” framework—Access, Awareness, Advocacy, Action, Accountability—to guide inclusive practices and improve organisational and financial outcomes.